-
Innovation Ranking
NewInnovation Ranking – Fortress Biotech Inc
Fortress Biotech Inc (Fortress Biotech), formerly Coronado Biosciences Inc, identifies, acquires, develops, and commercializes marketed pharmaceuticals and development-stage pharmaceutical product candidates. The company provides business, scientific, regulatory, and legal support for advancing the products or product candidates of its partner firms. It is a marketing partner for various branded drugs indicated for the treatment of radiation dermatitis, severe acne, athlete’s foot, inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and other skin infections. Fortress Biotech is headquartered in New York, the...
-
Product Insights
NewNet Present Value Model: Fortress Biotech Inc’s Olafertinib
Empower your strategies with our Net Present Value Model: Fortress Biotech Inc's Olafertinib report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Fortress Biotech Inc’s CUTX-101
Empower your strategies with our Net Present Value Model: Fortress Biotech Inc's CUTX-101 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Company Insights
Innovation and Patenting activity of New Fortress Energy Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of New Fortress Energy Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Thematic Analysis
NewWeb3 – Thematic Intelligence
Web3 is an ideology that refers to the next iteration of the internet built on blockchain. It promises a mix of peer-to-peer (P2P) communication channels and decentralized governance, leading the internet’s transition from an information-centric model to a user-centric model. Web3 aims to give users the ability to create, own, and monetize their content and manage the use of their data. This will be stored on blockchains instead of on third-party servers.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dotinurad in Gouty Arthritis (Gout)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dotinurad in Gouty Arthritis (Gout) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dotinurad in Gouty Arthritis (Gout) Drug Details: Dotinurad (Urece) acts as...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Dotinurad in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dotinurad in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dotinurad in Chronic Kidney Disease (Chronic Renal Failure)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MK-3475A in Metastatic Renal Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MK-3475A in Metastatic Renal Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MK-3475A in Metastatic Renal Cell Carcinoma Drug Details: MK-3475A...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabozantinib S-malate in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabozantinib S-malate in Esophageal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabozantinib S-malate in Esophageal Cancer Drug Details: Cabozantinib s-malate (XL184, BMS907351,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Camrelizumab in Urethral Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Camrelizumab in Urethral Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Camrelizumab in Urethral Cancer Drug Details: Camrelizumab (Airuika) is a humanized monoclonal...